Provides students with the opportunity to design new drug-like molecules targeting fibrotic diseases and malaria with cutting-edge drug discovery software CAMBRIDGE and NOTTINGHAM, UK – Optibrium™, a developer of software for drug discovery, today announced it had entered into a collaboration with the University of Nottingham, a pioneering research institution and university. Optibrium’s StarDrop™ software […]
Newton, NJ – Thorlabs announced today that it has signed a licensing agreement with Howard Hughes Medical Institute (HHMI) for exclusive rights to a new bessel beam-based, multiphoton volume imaging technique. The technique was originally developed at HHMI’s Janelia Research Campus in the lab of Dr. Na Ji, who now resides at the University of […]
Precipio ICE COLD-PCR™ reagents will be sold with PerkinElmer DNA/RNA extraction and isolation products NEW HAVEN, CT – Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), today announced an agreement with PerkinElmer to jointly offer Precipio’s ICE COLD-PCR (ICP) mutation enrichment technology together with PerkinElmer’s NextPrep-Mag™ cell-free DNA isolation kit, Janus® G3 liquid handling workstation, and chemagic™ MSM […]
Specialized CRO offers high-definition tissue imaging services for pharmaceutical and clinical research SOUTH SAN FRANCISCO, Calif. and PORTLAND, Ore. — Sirona Dx, a leader in high-complexity genomics and proteomics services, today announced the introduction of Imaging Mass Cytometry™ services on the Fluidigm Hyperion™ Imaging System to advance biomarker discovery and therapeutic development. Sirona Dx is a specialized […]
First commercially available reference standard for microsatellite instability (MSI) testing Horizon Discovery’s reference material covers seven new MSI markers tested for on the Idylla™ platform MSI is a form of genetic instability that is predominantly found in colorectal, gastric and endometrial cancer and serves as a prognostic, diagnostic and predictive marker in the clinic Cambridge, […]
Dublin, Ireland, and Cambridge, UK – ERS Genomics Limited and DefiniGEN Ltd announced today a license agreement to provide DefiniGEN with access to ERS Genomic’s CRISPR/Cas9 genome editing technology patents. DefiniGEN will combine their best-in-class iPSC (induced Pluripotent Stem Cell) differentiation platform with CRISPR/Cas9 technology to generate a range of innovative preclinical human models. “The company’s […]
-Dovetail increases global footprint with seven new distributors – SANTA CRUZ, Calif. — Dovetail Genomics™ LLC, which offers genomic products and services to address unmet needs in both human and non-human markets, expanded its growing international distribution network by signing additional partnerships in India, Australia, New Zealand, Taiwan, China, Thailand and Vietnam. Dovetails tools are used to generate accurate chromosome scale genome assemblies, identify large […]
SAN ANTONIO, TX and HAYWARD, CA – Paragon Genomics, Inc., a leader in amplicon-based target enrichment and library preparation solutions for next-generation sequencing (NGS) assays today announced a partnership with SOPHiA GENETICS designed to accelerate the global adoption of Data-Driven Medicine worldwide. Under the terms of the agreement, Paragon Genomics’ CleanPlex® NGStarget enrichment technologies will be […]
COLOGNE, Germany & LEIDEN, Netherlands & CAMBRIDGE, England–Ncardia, a leader in human iPSC-based solutions for drug safety and efficacy screening, and Horizon Discovery Group plc (LSE:HZD) (Horizon), a global leader in gene editing and gene modulation technologies, announced a partnership to provide custom genetically modified and differentiated human iPSC-derived cells (hiPSC) for drug discovery researchers. […]
SALT LAKE CITY–Privately held XCR Diagnostics Inc. and Luminex Corporation (Nasdaq:LMNX) have entered into a non-exclusive, worldwide license agreement for XCR’s proprietary Xtreme Chain Reaction nucleic acid amplification technology. The XCR technology enables extremely rapid thermal cycling protocols to achieve dramatically reduced assay turnaround times compared to traditional polymerase chain reaction. Financial terms were not disclosed. “XCR […]
Pay Invoice
Latest Blogs
-
Laboratory Tool Companies’ Dividends Show Stability
September 29, 2026 10:14 am
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
